|
|
 |
|
|
 |
|
|
| |
 |
| |
 |
| |
 |
|
|
Jonathan J. Fleming
- Managing General Partner
Boston, MA
Jonathan Fleming is the Managing General Partner of Oxford Bioscience Partners, an international venture capital firm specializing in life science technology based investments, with offices in Boston and Connecticut.
- more
|
 |
 |
|
|
Matthew A. Gibbs
- General Partner
Boston, MA
Matthew Gibbs is a General Partner of Oxford Bioscience Partners and Oxford Energy Partners, the energy focused affiliate fund of Oxford, a Billion dollar venture capital firm. Mr. Gibbs joined Oxford in 1997 and became a General Partner in 2005. Mr. Gibbs has over 17 years of venture capital experience.
- more
|
|
 |
|
|
Ellen S. Baron, Ph.D.
- Partner
Boston, MA
Dr. Baron joined Oxford Bioscience Partners in 2003 and is currently a Partner at the firm. She has over 20 years of operating and investment expertise in the pharmaceutical and biotechnology industry and is focused on all areas of healthcare investing, principally in biotherapeutics.
- more
|
|
 |
|
|
B. Christopher Kim, Ph.D.
- Partner
Boston, MA
Dr. Kim has extensive experience in life sciences operations as well as scientific research. He is Founding Partner of the Korea-Seoul Life Science Fund (KSLSF) which was launched in early 2011.
- more
|
|
 |
|
|
Edmund M. Olivier
- Senior General Partner
Malibu, CA
Mr. Olivier has a profitable record of financing and managing biotechnology and healthcare investments over the last 20 years.
- more
|
|
 |
|
|
Cornelius T. Ryan
- Founding General Partner
Westport, CT
Cornelius T. Ryan (Neil) co-founded Oxford Partners in 1981 and is the only partner involved in all previous Oxford funds. Neil is a Special Limited Founding Partner of Oxford Bioscience III and a General Partner of Oxford Bioscience I and II. - more
|
|
 |
|
|
Alan G. Walton, Ph.D., D.Sc.
- Senior General Partner
Westport, CT
Alan G. Walton, Ph.D., D.Sc. has served as a director of our company since March 2003. Dr. Walton joined Oxford Partners as a General Partner in 1987.
- more
|
|
| |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|